Study IDs Factors Linked to Risk for Transfer From Peritoneal Dialysis to Hemodialysis

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 26, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Feb. 26, 2025 -- Nurse assistance is associated with a lower risk for transfer from peritoneal dialysis (PD) to hemodialysis (HD) for infection in the first 18 months and for adequacy issues after six months, according to a study published online Feb. 7 in Kidney360.

Nanti E. Adoukonou, from Centre François Baclesse in Caen, France, and colleagues compared the risks for the different reasons for transfer to HD in PD patients according to use of assistance for PD care, PD modality, and suboptimal starter status in a retrospective study. The study included 15,974 PD patients from 170 PD units who started treatment between Jan. 1, 2002, and Dec. 31, 2018.

The researchers identified 6,835 deaths, 5,108 transfers to HD, and 3,092 renal transplantations. Nurse-assisted PD was associated with a reduced risk for transfer to HD for infection in the first 18 months and for adequacy issues after six months (cause-specific hazard ratio [HR], 0.51; 95 percent confidence interval [CI], 0.31 to 0.83 [before six months] and HR, 0.59; 95 percent CI, 0.51 to 0.70 [beyond 18 months]). A higher risk for transfer for mechanical issue was seen for continuous ambulatory PD (CAPD) than automated PD during the first 18 months (HR, 1.41; 95 percent CI, 1.00 to 1.99 [before six months]), but lower risks for adequacy, infectious, or mechanical issues were seen in association with CAPD after 18 months. A higher risk for transfer due to psychosocial challenges was seen with suboptimal starters in the first six months (HR, 1.70; 95 percent CI, 1.03 to 2.81).

"Recognizing these risk factors could help target specific patients with tailored preventive measures to reduce the risk of transfer for each particular cause," the authors write. "Further studies would be needed to explore the effect of such measures."

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-02-27 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords